Data protection Impressum

Medical Devices

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.

Spineart raises CHF 25 million to accelerate global expansion and innovation

6 October 2025

Geneva-based Multiwave Technologies has secured CHF 3.6 million to accelerate regulatory approval of its portable MRI device and establish a new assembly facility in the United States.

Multiwave raises CHF 3.6 million and opens US operations in Boston

1 October 2025

Switzerland Innovation has launched an interactive map to simplify access to its network of innovation parks, offering international companies and partners a clearer entry point into Switzerland’s diverse R&D landscape.

Switzerland Innovation unveils new map to strengthen international visibility of its ecosystem

29 September 2025

Geneva-based EarlySight has raised an additional CHF 3.1 million, bringing its seed financing round to CHF 6.1 million, to launch its next-generation product and advance U.S. approval.

Retinal imaging specialist EarlySight raises CHF 3.1 million to accelerate global growth

10 September 2025

A new automated platform developed by cellvie and CSEM streamlines mitochondria isolation, advancing therapeutic transplantation for ischemia-reperfusion injury.

CSEM and cellvie automate mitochondria isolation for clinical use

9 September 2025

Bern-based medtech Rhovica Neuroimaging has secured CHF 2.3 million to accelerate development of its SoNav system for safer emergency neurosurgery.

Rhovica raises CHF 2.3 million to advance bedside neurosurgery navigation

2 September 2025

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Geneva strengthens its support for breakthrough innovation with new FIF funding awarded to InTeeth, Speqqle, and 4D-PicoSense.

Three Geneva start-ups receive support from the FONGIT Innovation Fund

9 July 2025

1 2 3 4 5 … 13